title: Budd-chiari syndrome causing acute liver failure: A multicenter case series.
abstract: Budd-Chiari syndrome (BCS) is a rare disease resulting from obstruction of the hepatic venous outflow tract that typically presents with abdominal pain, jaundice, and ascites without frank liver failure. However, BCS may also evolve more rapidly to acute liver failure (ALF). In this study, we describe the clinical features, treatment, and outcomes of ALF due to BCS and compare our results with those in the published literature. Twenty of the 2344 patients enrolled in the Acute Liver Failure Study Group (ALFSG) registry since 1998 presented with a clinical diagnosis of BCS. An additional 19 patients of ALF-BCS in the English language literature were reviewed and compared with the ALFSG cases. Most ALF-BCS patients were white (84%) and female (84%) in their fourth decade. A hypercoagulable state was noted in 63% of patients. BCS was diagnosed by Doppler ultrasonography or abdominal computed tomography in all patients. Liver biopsies (n = 6) all had evidence of severe pericentral necrosis. Treatments used included most commonly anticoagulation (71%), but also transjugular intrahepatic portosystemic shunt (TIPS; 37%) and orthotopic liver transplantation (37%). In-hospital mortality was approximately 60%. In conclusion, BCS is a rare cause of ALF and mandates prompt diagnosis and management for successful outcomes. Once the diagnosis is confirmed, prompt anticoagulation is recommended in conjunction with evaluation for malignancy or thrombophilic disorder. Mortality may have improved in recent years with use of TIPS and/or orthotopic liver transplantation compared with prior published reports. Liver Transplantation 23 135-142 2017 AASLD.
authors.affiliation: Department of Surgery, University of Texas Southwestern Medical Center at Dallas, Dallas, TX.
authors.forename: Justin
authors.initials: J
authors.lastname: Parekh
authors.affiliation: Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX.
authors.forename: Vlad M
authors.initials: VM
authors.lastname: Matei
authors.affiliation: Gastroenterology Division HSJD, University of Costa Rica, San Pedro Montes de Oca, Costa Rica.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Canas-Coto
authors.affiliation: Texas Digestive Disease Consultants, Keller, TX.
authors.forename: Daniel
authors.initials: D
authors.lastname: Friedman
authors.affiliation: Department of Digestive and Liver Diseases Division, University of Texas Southwestern Medical Center at Dallas, Dallas, TX.
authors.forename: William M
authors.initials: WM
authors.lastname: Lee
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001706:Biopsy; D006502:Budd-Chiari Syndrome / Q000150:complications* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D017114:Liver Failure, Acute / Q000209:etiology* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D019168:Portasystemic Shunt, Transjugular Intrahepatic; D035583:Rare Diseases / Q000150:complications*; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D018608:Ultrasonography, Doppler; D055815:Young Adult
chemical_list: D000925:Anticoagulants